Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients

Cirrhosis Portal Clinical Trial

— Portalflow  

Official title:

Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05228509
• Other study ID #: Patef
• Status: Recruiting
• Start date: May 4, 2021
• Est. completion date: December 30, 2024

Study information

• Verified date: January 2024
• Source: Assiut University
• Contact: Peter At Rizk
• Phone: 01553529181
• Email: Peteratef662[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Portal vein flow velocity as screening tool for prediction of oesophageal varices in cirrhotic patient without upper endoscopy

Description:

Portal vein flow velocity as screening tool for prediction of oesophageal varices in cirrhotic patient without upper endoscopy with its high cost & complications Using portal vein flow velocity and the relation between it & presence of oesophageal varices in cirrhotic patient & its efficacy as a primary tool for these cases

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 75
• Est. completion date: December 30, 2024
• Est. primary completion date: December 2, 2024
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• cirrhotic patients with oesophageal varices
• cirrhotic patients without oesophageal varices

Exclusion Criteria:

• Patients with hepato-cellular carcinomas [HCCs], portal vein thrombosis, hepatic encephalopathy.
• Patients with positive HCV antibody, but without liver cirrhosis diagnostic criteria

Related Conditions & MeSH terms

• Cirrhosis Portal

Locations

Country	Name	City	State
Egypt	43	Assiut	Manfalout
Egypt	Egypt .assiut.manfalout	Assiut	Manfalout

Sponsors (1)

Lead Sponsor	Collaborator
Peter atef

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Using upper GIT endoscopy to detect the presence or absence of oesophageal varices	Non-invasive screening tool for esophageal varices: Aspartate aminotransferase-to-platelet ratio index (APRI) ... Doppler ultrasound of portal system Elastography both of liver and spleen... -Research outcome measures: a. Primary (main): Using upper GIT endoscopy to detect the presence or absence of oesophageal varices, and to detect the best and most available non- invasive predictor for it.	3 years